Course offering: Introduction to Medical Affairs in Medicines Development
Don’t miss out on this exciting new course covering the fundamentals of Medicines Development and how Medical Affairs functions bring [...]
How Does Consolidation Drive Prices?
Why do Americans spend so much on healthcare? According to a recent literature review, part of the reason may be [...]
Kamala Harris Is No Friend to Pharma
Vice presidential nominee Kamala Harris is not exactly the centrist the media are making her out to be—especially when it [...]
Towards a Better Understanding of Outcome-Based Contracts
Outcome-based contracting is an operational model that requires an ironclad relationship between customer and provider that provides the trust necessary [...]
Although COVID-19 has Dampened Pharma Sales in 2020, Outlook to 2026 is still Optimistic
According to the EvaluatePharma World Preview 2020, Outlook to 2026 report, COVID-19 has reduced biopharma sales forecasts by $7.85bn with [...]
The Most Expensive Drugs in the U.S. According to GoodRx
GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare [...]
Proposed change to CMS Rules Aim Will Expand Access to High-cost Therapies for Medicaid Recipients
The Medicaid Best Price rule requires drug manufacturers to give Medicaid the best price on all purchases. However, the rule [...]
How COVID-19 Provides Opportunities to Implement Value-Based Care Practices
COVID-19 has drastically changed the healthcare landscape for payers and providers as telehealth services are increasingly utilized. Experts discussed how [...]
Webinar Recap: It’s Time to Talk About COVID-19 Prices
Join National Pharmaceutical Council Chief Science Officer Robert Dubois, Memorial Sloan Kettering Cancer Center's Peter Bach, Institute for Clinical and [...]
Value-based Models Achieve Better Patient Outcomes in Primary Care Practices
A new study from United Health Group shows that primary care physicians (PCPs) perform better on key quality metrics when [...]
How Effective is Precision Medicine in the Fight Against Lung Cancer?
Precision medicine, an approach that relies on drugs that target specific genes, has produced specular results by saving many individual [...]
Post-Pandemic Paradigm Shifts and New Dimensions of Value, a DIA DIRECT webinar
The current pandemic has forced us to recognize the weaknesses of our current social, economic, and healthcare systems and rethink [...]
BHE Rebrands Itself as Panalgo In Effort To Empower Pharma, Payers and Providers With Trusted Analytics.
BHE has rebranded itself as Panalgo to better expand access to reliable health analytics using their Instant Health Data (IHD) [...]
Toward A More Precise Public Health Strategy in the Battle Against COVID-19
COVID-19 is one of the greatest public health challenges ever to face United States with cases in excess of 5,000,000. [...]
New Roadmap Aims to Transform Healthcare Landscape by Minimizing Low Value Services
The COVID-19 pandemic is causing financial disruption and turbulence on an unprecedented scale raising further questions on how to best [...]
Germany’s Experiment With Drug Price Regulation: Aligning Clinical Benefit With Cost of Cancer Drugs
According to a new study, Germany’s move to reform pharmaceutical spending has resulted in closer alignment between clinical benefit and [...]
What a tangled web we weave: The complex relationship between PBMs and GPOs
Join Avalere Health principal Mike Schneider as he discusses why traditional Pharmacy Benefit Managers (PBMs) are deciding that now may [...]
Free Strategic Playbook Aims to Bring Cures to Patients More Efficiently
Harvard Business School’s Kraft Precision Medicine Accelerator announced the launch of a playbook specifically developed to bring vital assistance to [...]
Capping Out-of-Pocket Costs for Specialty Drugs Reduces Patient Spending By 32%
A recently published study in the New England Journal of Medicine found that capping out-of-pocket costs for specialty drugs resulted [...]
MMIT releases Special Report on Value Based Agreements (VBA’s) Between Payers and Manufacturers
A special report launched by MMIT aims to provide guidance on value-based contracting discussion with evidence-based insights. Some key highlights: [...]
Lilly + Prime Therapeutics Push the Envelope on Next Generation Value-based Agreements
Lilly has partnered with Prime Therapeutics to explore how value-based arrangements (VBA’s) can be used to improve patient outcomes while [...]
AMCP Collaborate Platform Enhances Collaboration to Support and Inform Managed Care Pharmacy
AMCP Collaborate is a platform for AMCP members to connect and share ideas and solutions about the most vexing challenges [...]
Health Economics & Outcomes Research (HEOR) Services Market Research Report 2020 Just Released
Intellectual Research Partners has released the Health Economics & Outcomes Research (HEOR) Services Market Research Report 2020.The report details the [...]
Optum leverages natural language processing system (NLP) to provide oncology- related insights
Making data available to researcher through extracting essential information from oncological medical records is one of Optum’s key oncology data [...]
Key Innovations Coming From The Next Generation of PBM’s
The world of pharmacy benefit management (PBM) will change dramatically over the next five years and much of the change is coming from [...]